The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
October 4th 2024
Crisugabalin at 40 mg/d or 80 mg/d significantly reduced daily pain in adults with postherpetic neuralgia, a phase 3 study found.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
How to Manage Anticoagulation in Patients with Bleeding Disorders
Patients suffering from the most common hereditary bleeding disorder von Willebrand disease (VWD) also undergoing surgical procedures are recommended specific treatment methods to manage perioperative anticoagulation.
Psoriasis Treatment May Trigger Significant Adverse Effects
Study results suggest that a treatment for psoriasis and multiple sclerosis may induce a dangerous adverse effect, particularly in women. The finding is potentially important, because while treatment with fumaric acid esters has been around for more than 40 years, it is now being used more widely in the United States, Germany, and other areas.
Opioid Prescription Practices May Influence Pain Episodes in Pediatric Sickle Cell Disease
December 2nd 2015Thirty-day emergency room readmissions due to acute pain is not uncommon in children with sickle cell disease, and researchers suspect that opioid prescription practices has something to do with it.
Muscle Strength and Flexibility Linked to Pain for Women with Fibromyalgia
November 19th 2015It may be easy to write a prescription for opioids in hopes that they will do the trick for patients struggling with fibromyalgia pain. But the best path towards effective analgesia may not require medication at all.
Morphine Regulator May Reduce Pain-Kill Abuse Risk
November 16th 2015Researchers appear to have identified a specific molecule that controls morphine receptor signaling in a small group of brain cells. The particular regulator of G protein signaling protein is called RGS7 and has been identified as a novel regulator of the μ-opioid receptor, which morphine acts upon to mediate its euphoric and analgesic effects.
Depression and Mood Influence Pain in Rheumatoid Arthritis Patients
Researchers report that in patients with rheumatoid arthritis (RA), greater positive mood throughout daily life was linked to less pain and fewer RA-related restrictions, while negative mood was linked to an increase in RA-related restrictions.
Tofacitinib Effective for Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
In a post-hoc analysis, researchers found that the clinical efficacy of tofacitinib after 6 months of treatment was greater than placebo, and appeared similar regardless of methotrexate dose.
Sarilumab Plus DMARD Improves Fatigue, Pain for Patients with Rheumatoid Arthritis
Patients with rheumatoid arthritis who received sarilumab plus a DMARD who did not respond to anti-TNF medications showed statistically significant and clinically meaningful changes from baseline in fatigue, morning stiffness, pain, productivity, and participation at week 24.